 Corynebacterium parvum versus Calmette-Guerin adjuvant immunotherapy stage II malignant melanoma separate studies Corynebacterium parvum Calmette-Guerin BCG adjuvant immunotherapy stage II melanoma patients Milton Hershey Medical Center patients Southeastern Cancer Study Group SECSG patients criteria patient selection drugs similar data effects treatments studies BCG Tice Chicago IL organisms treatment Tine technique parvum Burroughs-Wellcome Triangle Park NC dose SECSG Hershey treatment difference studies frequency immunization patients Hershey doses SECSG patients doses period treatment Kaplan-Meier life-table analysis patients prolonged disease-free interval patients parvum two-sided Mantel procedure similar fashion patients parvum survival rate causes BCG-treated patients analysis results patients number positive nodes available Cox model nodes stratification variable covariates place treatment age sex analysis observed benefit parvum disease-free interval value benefit parvum survival times causes value analysis patients years observed benefit parvum disease-free interval value benefit parvum survival times causes value